Chemotherapy of advanced and recurrent cervical carcinoma

Seminars in Surgical Oncology

Volumn 16, Issue 3, 1999, Pages 247-250

  Nguyen, Hoa N ^a   Nordqvist, Staffan R B ^a  

^a Sheridan Health Care Corporation   (United States)

Author keywords

Adjuvant chemotherapy; Adjuvant radiotherapy; Bleomycin; C yclophosphamide; Carboplatin; Cervix neoplasms; Cisplatin; Combination drug therapy; Combined antineoplastic agents; Combined modality therapy; Doxorubicin; Drug evaluation; Hydroxyurea; Ifosfamide; Local neoplasm recurrence; Mitolactol; Mitomycin C; Neoplasm metastasis; Neoplasm staging; Radiotherapy; Survival rate; Vincristine

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; HYDROXYUREA; IFOSFAMIDE; MISONIDAZOLE; MITOLACTOL; MITOMYCIN C; PACLITAXEL; VINBLASTINE; VINCRISTINE;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CHEMOTHERAPY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIATION-SENSITIZING AGENTS; UTERINE CERVICAL NEOPLASMS;

EID: 0032943761     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199904/05)16:3<247::AID-SSU10>3.0.CO;2-4     Document Type: Article

References (28)

1. Averette HE, Donato DM, Lovecchio JL, Sevin BU: Surgical staging of gynecologic malignancies [Review]. Cancer 1987;60: 2010-2021.
2. th ed. Philadelphia: Churchill Livingstone; 1998. p. 424-427.
3. Thigpen JT: The role of chemotherapy in gynecologic cancer. In Rubin SC (ed): "Chemotherapy of gynecologic cancers". Philadelphia: Lippincott-Raven; 1996. p. 100-104.
4. Omura GA: Chemotherapy for cervix cancer [Review]. Semin Oncol 1994;21:54-62.
5. Bonomi P, Blessing JA, Stehman FB, et al: Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1985;3:1079-1085.
6. Thigpen T, Lambuth BW, Vance RB: Ifosfamide in the management of gynecologic cancers [Review]. Semin Oncol 1990;17(2 Suppl 4):11-18.
7. Sutton GP, Blessing JA, Adcock L, et al: Phase II study of ifosfamide and mesna in patients with previously treated carcinoma of the cervix. A Gynecologic Oncology Group study. Invest New Drug 1989;7:341-343.
8. Sutton GP, Blessing JA, Photopoulos G, et al: Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies. Semin Oncol 1989;16(1 Suppl 3):68-72.
9. Lira-Puerto V, Piccart M, Wiernik P: A comparison of U.S. and Mexican experience with single drug therapy in advanced cervical cancer. (NCI-PAHO and ECOG study) [Abstract]. Proc Am Soc Clin Oncol 1985;4:117.
10. Stehman FB, Blessing JA, McGehee R, Barrett RJ: A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1989;7:1892-1895.
11. Baker L, Boutselis J, Alberts D, et al: Combination chemotherapy for patients with disseminated carcinoma of the uterine cervix [Abstract]. Proc Am Soc Clin Oncol 1985;4:120.
12. Bonomi P, Blessing J, Ball H, et al: A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1989;34:357-359.
13. Hoffman MS, Kavanagh JJ, Roberts WS, et al: A phase II evaluation of cisplatin, bleomycin, and mitomycin-C in patients with recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 1991;40:144-146.
14. Buxton EJ, Meanwell CA, Hilton C, et al: Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer. J Natl Cancer Inst 1989;81:359-361.
15. Thigpen T, Vance R, Khansur T, Malamud F: The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix [Review]. Semin Oncol 1996;23(3 Suppl 6):56-64.
16. Thigpen T, Vance R, Khansur T, Malamud F: The role of paclitaxel in the management of patients with carcinoma of the cervix [Review]. Semin Oncol 1997:24(1 Suppl 2):S2-41-S2-46.
17. Omura GA, Blessing JA, Vacarello L, et al: Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1997;15: 165-171.
18. Hreshchyshyn MM, Aron BS, Boronow RC, et al: Hydroxyurea of placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys 1979;5:317-322.
19. Stehman FB, Bundy BN, Keys H, et al: A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. Am J Obstet Gynecol 1988;159:87-94.
20. Byfield JE, Calabro-Jones P, Klisak I, Kulhanian F: Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays. Int J Radiat Oncol Biol Phys 1982;8:1923-1930.
21. Douple EG: Interactions between platinum coordination complexes and radiation. In Hill BT, Bellamy AS (eds): "Antitumor drug-radiation interactions". Boca Raton, Florida: CRC Press; 1990. p.171.
22. John M, Flam M, Sikic B, et al: Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG study. Gynecol Oncol 1990;37:1-5.
23. Nguyen PD, John B, Munoz AK, et al: Mitomycin-C/5-FU and radiation therapy for locally advanced uterine cervical cancer. Gynecol Oncol 1991;43:220-225.
24. nd ed. New York Alan R. Liss; 1990. p. 121-153.
25. Park TK, Choi DH, Kim SN, et al: Role of induction chemotherapy in invasive cervical cancer. Gynecol Oncol 1991;41:107-112.
26. Deppe G, Malviya VK, Han I, et al: A preliminary report of combination chemotherapy with cisplatin and mitomycin-C followed by radical hysterectomy or radiation therapy in patients with locally advanced cervical cancer. Gynecol Oncol 1991;42:178-181.
27. Panici PB, Greggi S, Scambia G, et al: High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervical carcinoma: a preliminary report. Gynecol Oncol 1991;41:212-216.
28. Giaroli A, Sananes C, Sardi JE, et al: Lymph node metastases in carcinoma of the cervix uteri: response to neoadjuvant chemotherapy and its impact on survival. Gynecol Oncol 1990;39:34-39.